Page last updated: 2024-12-05

4-nitrobiphenyl

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitrobiphenyl: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7114
CHEMBL ID352531
CHEBI ID82504
SCHEMBL ID167524
MeSH IDM0120411

Synonyms (59)

Synonym
AC-18837
1,1'-biphenyl, 4-nitro-
1-nitro-4-phenyl-benzene
ccris 443
hsdb 2632
4-phenyl-nitrobenzene
einecs 202-204-7
ai3-00635
nsc 1324
p-phenyl-nitrobenzene
4-nitro-1,1'-biphenyl
STK364313
92-93-3
1-nitro-4-phenylbenzene
nsc1324
4-nitrobiphenyl
p-phenylnitrobenzene
biphenyl, 4-nitro-
PNB ,
4-phenylnitrobenzene
ba 2794
nsc-1324
wln: wnr dr
p-nitrodiphenyl
p-nitrobiphenyl
4-nitrodiphenyl
inchi=1/c12h9no2/c14-13(15)12-8-6-11(7-9-12)10-4-2-1-3-5-10/h1-9h
bajqrlzapxasrd-uhfffaoysa-
4-nitro-biphenyl
CHEMBL352531
chebi:82504 ,
AKOS000121470
BBL000538
unii-qm80nuw6wz
qm80nuw6wz ,
4-nitrolbiphenyl
C19473
28984-85-2
1,1'-biphenyl, nitro-
FT-0672778
FT-0631459
CS-B0269
SCHEMBL167524
p-nitrobiphenyl [hsdb]
p-nitrobiphenyl [mi]
4-nitrobiphenyl [iarc]
nitro-1,1'-biphenyl, 4-
4-(4-nitrophenyl)benzene
mfcd00007342
4-nitro-1,1'-biphenyl #
DTXSID9041522
J-002964
GS-3776
4-nitrobiphenyl 10 microg/ml in cyclohexane
DB12300
Z57127477
Q20966444
4-nitro-1
EN300-18005

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The numerous toxic manifestations are discussed."( Nitroaromatic compounds: Environmental toxicity, carcinogenicity, mutagenicity, therapy and mechanism.
Kovacic, P; Somanathan, R, 2014
)
0.4

Dosage Studied

ExcerptRelevanceReference
" Linear dose-response relationships were obtained for supercritical CO2-extracted EDB using tester strain TA100 (+/- S9) and for 4-NB using tester strains TA98 and TA100 (-S9)."( Quantitative integration of the Salmonella microsuspension assay with supercritical fluid extraction of model airborne vapor-phase mutagens.
Hsieh, DP; Kado, NY; Kuzmicky, PA; Ning, H; Seiber, JN; Wong, JM; Woodrow, JE, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
biphenylsBenzenoid aromatic compounds containing two phenyl or substituted-phenyl groups which are joined together by a single bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID23442Partition coefficient (logP)1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
AID1486519Binding affinity to transthyretin in human blood plasma assessed as plasma binding selectivity by measuring stoichiometry of small molecule bound to TTR incubated for 24 hrs at 37 degC by RP-HPLC2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID1486518Inhibition of acid-induced wild type transthyretin (unknown origin) aggregation expressed in Escherichia coli pre-incubated for 30 mins before acid addition and further incubated for 72 hrs at 37 degC under dark conditions by UV-Vis spectrophotometry2017Bioorganic & medicinal chemistry letters, 08-01, Volume: 27, Issue:15
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
AID200690Mutagenic activity in an Ames test on Salmonella Typhimurium TA98; Activity is log of revertants/nmol1991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Structure-activity relationship of mutagenic aromatic and heteroaromatic nitro compounds. Correlation with molecular orbital energies and hydrophobicity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (44.44)18.7374
1990's5 (27.78)18.2507
2000's2 (11.11)29.6817
2010's3 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.00

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.00 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.79 (4.65)
Search Engine Demand Index33.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.00)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (16.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]